Medtech company Stryker reported sales increases across multiple portfolios in the third quarter, according to financial results posted Oct. 30.
Five notes on the company’s financial performance for the third quarter of 2025:
1. Stryker reported an overall net sales increase of 10.3%, hitting $6.1 billion.
2. The company reported $3.8 billion in sales for its medical and surgical equipment and neurotechnology, a 14.4% increase.
3. Orthopedic net sales were $2.3 billion, a 3.9% increase.
4. Stryker reported net earnings of $859 million.
5. The company raised its full-year guidance for 2025, now expecting organic net sales growth between 9.8% and 10.2%.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.